Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2024-10-15 00:00:00 ET · period of report 2024-10-11 · accession 0001062993-24-017675 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-10-15 | 2024-10-11 | RNAC | Seven One Eight Three Four Irrevocable Trust | 10% | M - OptEx | — | +1.52M | 4.56M | +50% | — |
| DI | 2024-10-15 | 2024-10-11 | RNAC | Seven One Eight Three Four Irrevocable Trust | 10% | M - OptEx | — | -45.6K | 56.4K | -45% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-11 | M | A | 1,518,373 | — | 4,555,260 | I as trustee | — | — | (F1) On October 11, 2024, Seven One Eight Three Four Irrevocable Trust (the "Trust") elected to convert a portion of its shares of the issuer's Series A Non-Voting Convertible Preferred Stock into shares of the issuer's common stock. The remaining shares of the issuer's Series A Non-Voting Convertible Preferred Stock held by the Trust are subject to a beneficial ownership limitation. (F2) Shares are held by the Trust. The reporting person is a trustee of the Trust. |
| 2 | Derivative | Series A Non-Voting Convertible Preferred Stock | 2024-10-11 | M | D | 45,551.19 | — | 56,402.25 | I as trustee | — · — to — | 1,518,373 Common Stock | (F3) On November 13, 2023, the issuer acquired the private Delaware corporation which was then known as Cartesian Therapeutics, Inc. in accordance with the terms of an Agreement and Plan of Merger, dated November 13, 2023 (the "Merger"). These securities represent merger consideration payable as a result of the closing of the Merger and securities purchased in a private placement in November 2023. (F2) Shares are held by the Trust. The reporting person is a trustee of the Trust. (F1) On October 11, 2024, Seven One Eight Three Four Irrevocable Trust (the "Trust") elected to convert a portion of its shares of the issuer's Series A Non-Voting Convertible Preferred Stock into shares of the issuer's common stock. The remaining shares of the issuer's Series A Non-Voting Convertible Preferred Stock held by the Trust are subject to a beneficial ownership limitation. |